FCG Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $291K | Sell |
3,318
-16
| -0.5% | -$1.4K | 0.07% | 143 |
|
|
2020
Q2 | $327K | Sell |
3,334
-12
| -0.4% | -$1.18K | 0.09% | 106 |
|
|
2020
Q1 | $255K | Buy |
3,346
+6
| +0.2% | +$457 | 0.07% | 121 |
|
|
2019
Q4 | $296K | Buy |
3,340
+204
| +7% | +$18.1K | 0.08% | 126 |
|
|
2019
Q3 | $237K | Buy |
3,136
+201
| +7% | +$15.2K | 0.07% | 138 |
|
|
2019
Q2 | $213K | Buy |
2,935
+85
| +3% | +$6.17K | 0.07% | 145 |
|
|
2019
Q1 | $230K | Sell |
2,850
-282
| -9% | -$22.8K | 0.08% | 131 |
|
|
2018
Q4 | $289K | Buy |
3,132
+3
| +0.1% | +$277 | 0.11% | 102 |
|
|
2018
Q3 | $296K | Buy |
3,129
+3
| +0.1% | +$284 | 0.1% | 107 |
|
|
2018
Q2 | $290K | Buy |
3,126
+2
| +0.1% | +$186 | 0.11% | 101 |
|
|
2018
Q1 | $296K | Sell |
3,124
-15
| -0.5% | -$1.42K | 0.1% | 100 |
|
|
2017
Q4 | $302K | Buy |
3,139
+19
| +0.6% | +$1.83K | 0.11% | 92 |
|
|
2017
Q3 | $277K | Buy |
3,120
+2
| +0.1% | +$178 | 0.1% | 96 |
|
|
2017
Q2 | $226K | Buy |
3,118
+3
| +0.1% | +$217 | 0.08% | 128 |
|
|
2017
Q1 | $203K | Buy |
+3,115
| New | +$203K | 0.08% | 117 |
|
|
2015
Q1 | – | Sell |
-3,665
| Closed | -$245K | – | 100 |
|
|
2014
Q4 | $245K | Buy |
+3,665
| New | +$245K | 0.12% | 96 |
|